Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
53
GFR Quote, Financials, Valuation and Earnings
Last price:
$4.29
Seasonality move
:
8.82%
Day range:
$4.10 - $4.28
52-week range:
$3.81 - $8.16
Dividend yield:
0%
P/E ratio:
2.25x
P/S ratio:
0.52x
P/B ratio:
0.50x
Volume:
44.7K
Avg. volume:
51.9K
1-year change:
-46.27%
Market cap:
$293.6M
Revenue:
$600.4M
EPS (TTM):
$1.86
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $215.9M | $767.7M | $500.6M | $600.4M | |
| Revenue Growth (YoY) | -- | -- | 255.61% | -34.79% | 19.92% | |
| Cost of Revenues | -- | $104.7M | $373.6M | $293.6M | $321.1M | |
| Gross Profit | -- | $111.2M | $394.1M | $207M | $279.2M | |
| Gross Profit Margin | -- | 51.52% | 51.33% | 41.34% | 46.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $21.8M | $60.6M | $57M | $59.7M | |
| Other Inc / (Exp) | -- | $506.1M | -$115.4M | $37.6M | -$35.2M | |
| Operating Expenses | -- | $69.7M | $186.2M | $249.8M | $174.2M | |
| Operating Income | -- | $41.5M | $207.9M | -$42.8M | $105M | |
| Net Interest Expenses | -- | $20M | $58.7M | $81M | $43.2M | |
| EBT. Incl. Unusual Items | -- | $527.6M | $33.8M | -$86.1M | $26.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$67.4M | $14.4M | -$61.9M | |
| Net Income to Company | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Basic EPS (Cont. Ops) | -- | $7.69 | $1.47 | -$1.84 | $1.28 | |
| Diluted EPS (Cont. Ops) | -- | $7.69 | $1.47 | -$1.84 | $1.24 | |
| Weighted Average Basic Share | -- | $68.6M | $68.6M | $54.4M | $69.2M | |
| Weighted Average Diluted Share | -- | $68.6M | $68.6M | $54.4M | $71.6M | |
| EBITDA | -- | $569.9M | $144.7M | -$1.3M | $120.9M | |
| EBIT | -- | $547.6M | $92.5M | -$51.5M | $62M | |
| Revenue (Reported) | -- | $215.9M | $767.7M | $500.6M | $600.4M | |
| Operating Income (Reported) | -- | $41.5M | $207.9M | -$42.8M | $105M | |
| Operating Income (Adjusted) | -- | $547.6M | $92.5M | -$51.5M | $62M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $132.8M | $149M | $127.7M | |
| Revenue Growth (YoY) | -- | -- | -- | 12.22% | -14.31% | |
| Cost of Revenues | -- | -- | $94.1M | $86M | $71.2M | |
| Gross Profit | -- | -- | $38.7M | $63M | $56.5M | |
| Gross Profit Margin | -- | -- | 29.16% | 42.29% | 44.22% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $13.9M | $13.9M | $17.3M | |
| Other Inc / (Exp) | -- | -- | $2.1M | -$45M | $9.7M | |
| Operating Expenses | -- | -- | $44.5M | $41.7M | $44.5M | |
| Operating Income | -- | -- | -$5.8M | $21.3M | $12M | |
| Net Interest Expenses | -- | -- | $11.3M | $11.1M | $8.2M | |
| EBT. Incl. Unusual Items | -- | -- | -$15M | -$34.8M | $13.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$2.7M | -- | $2.2M | |
| Net Income to Company | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.50 | $0.16 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.50 | $0.16 | |
| Weighted Average Basic Share | -- | -- | $68.6M | $68.7M | $69.9M | |
| Weighted Average Diluted Share | -- | -- | $68.6M | $68.7M | $70.5M | |
| EBITDA | -- | -- | $11.4M | -$11.9M | $36.1M | |
| EBIT | -- | -- | -$3.7M | -$25.1M | $21M | |
| Revenue (Reported) | -- | -- | $132.8M | $149M | $127.7M | |
| Operating Income (Reported) | -- | -- | -$5.8M | $21.3M | $12M | |
| Operating Income (Adjusted) | -- | -- | -$3.7M | -$25.1M | $21M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $516.8M | $578.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $285.4M | $306.1M | |
| Gross Profit | -- | -- | -- | $231.4M | $272.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $57.1M | $63M | |
| Other Inc / (Exp) | -- | -- | $50.8M | -$9.7M | $19.3M | |
| Operating Expenses | -- | -- | -- | $247.4M | $177.2M | |
| Operating Income | -- | -- | -- | -$16M | $95.4M | |
| Net Interest Expenses | -- | -- | $40.4M | $80.9M | $40M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$106.6M | $74.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $16.9M | -$58.2M | |
| Net Income to Company | -- | -- | -- | -$122.9M | $134.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$123.4M | $132.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$2.16 | $1.92 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$2.16 | $1.86 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -$24.7M | $167M | |
| EBIT | -- | -- | -- | -$73.1M | $106.4M | |
| Revenue (Reported) | -- | -- | -- | $516.8M | $578.7M | |
| Operating Income (Reported) | -- | -- | -- | -$16M | $95.4M | |
| Operating Income (Adjusted) | -- | -- | -- | -$73.1M | $106.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $132.8M | $149M | $127.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $94.1M | $86M | $71.2M | |
| Gross Profit | -- | -- | $38.7M | $63M | $56.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $13.9M | $13.9M | $17.3M | |
| Other Inc / (Exp) | -- | -- | $2.1M | -$45M | $9.7M | |
| Operating Expenses | -- | -- | $44.5M | $41.7M | $44.5M | |
| Operating Income | -- | -- | -$5.8M | $21.3M | $12M | |
| Net Interest Expenses | -- | -- | $11.3M | $11.1M | $8.2M | |
| EBT. Incl. Unusual Items | -- | -- | -$15M | -$34.8M | $13.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$2.7M | -- | $2.2M | |
| Net Income to Company | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.50 | $0.16 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.50 | $0.16 | |
| Weighted Average Basic Share | -- | -- | $68.6M | $68.7M | $69.9M | |
| Weighted Average Diluted Share | -- | -- | $68.6M | $68.7M | $70.5M | |
| EBITDA | -- | -- | $11.4M | -$11.9M | $36.1M | |
| EBIT | -- | -- | -$3.7M | -$25.1M | $21M | |
| Revenue (Reported) | -- | -- | $132.8M | $149M | $127.7M | |
| Operating Income (Reported) | -- | -- | -$5.8M | $21.3M | $12M | |
| Operating Income (Adjusted) | -- | -- | -$3.7M | -$25.1M | $21M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $47.7M | $26.1M | $82.6M | $47M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $27.5M | $16.5M | $16.9M | $33M | |
| Inventory | -- | $12.5M | $10.7M | $10.5M | $10.4M | |
| Prepaid Expenses | -- | $8.2M | $2.9M | $4.3M | $3.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $109.8M | $91M | $123.5M | $100.5M | |
| Property Plant And Equipment | -- | $775.8M | $709.6M | $709.6M | $668.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $885.5M | $865.2M | $884.6M | $876.2M | |
| Accounts Payable | $47.1K | $25.4M | $2.5M | $4.8M | $4.4M | |
| Accrued Expenses | -- | $16.2M | $6.1M | $9.9M | $7.2M | |
| Current Portion Of Long-Term Debt | -- | $86.6M | $46.6M | $33.4M | $173.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $72.2K | $4.5M | $4.9M | |
| Other Current Liabilities | -- | $24.1M | $19.9M | $14.4M | $12.9M | |
| Total Current Liabilities | $47.1K | $155.7M | $100.9M | $98.2M | $234M | |
| Long-Term Debt | -- | $168.8M | $140.8M | $250.3M | $56M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $47.1K | $332.7M | $247.9M | $360.7M | $303.8M | |
| Common Stock | -- | $11.8K | $11.1K | $119.5M | $114.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$47.1K | $552.8M | $617.3M | $523.9M | $572.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$47.1K | $552.8M | $617.3M | $523.9M | $572.3M | |
| Total Liabilities and Equity | -- | $885.5M | $865.2M | $884.6M | $876.2M | |
| Cash and Short Terms | -- | $47.7M | $26.1M | $82.6M | $47M | |
| Total Debt | -- | $255.3M | $187.5M | $283.7M | $229.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $66.8M | $50.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $30.7M | $26.1M | |
| Inventory | -- | -- | -- | $9.2M | $8.8M | |
| Prepaid Expenses | -- | -- | -- | $2.3M | $4.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $117.2M | $107M | |
| Property Plant And Equipment | -- | -- | -- | $715.9M | $675.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | $883.6M | $887.5M | |
| Accounts Payable | -- | -- | -- | $44.8M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $55.2M | $8.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $5.5M | $4.5M | |
| Other Current Liabilities | -- | -- | -- | $47.5M | $7.2M | |
| Total Current Liabilities | -- | -- | -- | $153.8M | $65M | |
| Long-Term Debt | -- | -- | -- | $231.9M | $221.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $403.9M | $301.9M | |
| Common Stock | -- | -- | -- | $118.1M | $115.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $479.7M | $585.6M | |
| Total Liabilities and Equity | -- | -- | -- | $883.6M | $887.5M | |
| Cash and Short Terms | -- | -- | -- | $66.8M | $50.5M | |
| Total Debt | -- | -- | -- | $287.1M | $230.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $909.3K | $7.3M | $4.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $25.5M | $126.6M | $64.1M | $105.4M | |
| Capital Expenditures | -- | $3.7M | $30.4M | $24.8M | $63.8M | |
| Cash Acquisitions | -- | -$286.8M | -- | -- | -$3.2M | |
| Cash From Investing | -- | -$268.4M | -$49M | -$9M | -$68.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$44M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $291.6M | -- | $283.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$95M | -$218.3M | -$66.5M | |
| Repurchase of Common Stock | -- | -- | -- | -$30.7M | -- | |
| Other Financing Activities | -- | -- | -- | -$40M | -$3.1M | |
| Cash From Financing | -- | $291.6M | -$95M | $1.5K | -$69.6M | |
| Beginning Cash (CF) | -- | -- | $46.8M | $26.2M | $79.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $48.7M | -$17.4M | $55.1M | -$33M | |
| Ending Cash (CF) | -- | $48.6M | $27.2M | $81.1M | $49.2M | |
| Levered Free Cash Flow | -- | $21.8M | $96.2M | $39.3M | $41.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $240.2K | $631.7K | $870.6K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$3.3M | $12.7M | $24.1M | |
| Capital Expenditures | -- | -- | $3.3M | $26.1M | $19.3M | |
| Cash Acquisitions | -- | -- | -- | -$1.9M | -- | |
| Cash From Investing | -- | -- | -$6.3M | -$27.9M | -$19.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$4.4K | -$37.8K | -$1.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$4.4K | -$37.8K | -$1.3M | |
| Beginning Cash (CF) | -- | -- | $26.1M | $81.2M | $46.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | $45.8K | $1M | -$71.6K | |
| Additions / Reductions | -- | -- | -$9.6M | -$15.3M | $3.4M | |
| Ending Cash (CF) | -- | -- | $16.6M | $66.9M | $50.2M | |
| Levered Free Cash Flow | -- | -- | -$6.6M | -$13.4M | $4.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$122.9M | $134.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $240.2K | $7.7M | $4.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $80.1M | $116.9M | |
| Capital Expenditures | -- | -- | $3.3M | $47.5M | $57M | |
| Cash Acquisitions | -- | -- | -- | -$1.9M | -$1.3M | |
| Cash From Investing | -- | -- | -- | -$30.6M | -$60.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$44M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$218.3M | -$67.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -$31.9K | -$70.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $49.4M | -$14.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $32.6M | $59.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$12.3M | -$34.8M | $11.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $240.2K | $631.7K | $870.6K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$3.3M | $12.7M | $24.1M | |
| Capital Expenditures | -- | -- | $3.3M | $26.1M | $19.3M | |
| Cash Acquisitions | -- | -- | -- | -$1.9M | -- | |
| Cash From Investing | -- | -- | -$6.3M | -$27.9M | -$19.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$4.4K | -$37.8K | -$1.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$4.4K | -$37.8K | -$1.3M | |
| Beginning Cash (CF) | -- | -- | $26.1M | $81.2M | $46.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | $45.8K | $1M | -$71.6K | |
| Additions / Reductions | -- | -- | -$9.6M | -$15.3M | $3.4M | |
| Ending Cash (CF) | -- | -- | $16.6M | $66.9M | $50.2M | |
| Levered Free Cash Flow | -- | -- | -$6.6M | -$13.4M | $4.8M | |
Get GFR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GFR
Sector
P/E ratio
2.25x
11.50x
PEG ratio
--
0.01x
P/B ratio
0.50x
1.01x
Price / LTM sales
0.52x
0.85x
Growth Metrics
GFR
Sector
Revenue growth
-14.31%
-0.23%
Earnings growth
611.17%
-9.79%
Revenue (5-year growth)
--
6.13%
Earnings forecast
$0.22
$0.20
Profitability
GFR
Sector
Profitability FY 2024
$279.2M
$92.9M
Return on invested capital
16.83%
3.61%
Return on assets
15.04%
2.38%
Return on equity
24.76%
5.96%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Aug
6
Balance Sheet
GFR
Sector
Total cash
$50.5M
$12.9M
Short term investments
--
$2.9M
Total assets
$876.2M
$380.4M
Long term debt
$230.3M
$122.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
